Table 4.

Main clinical characteristics of patients group according to ApoA1 and CRP levels

Variables	ApoA1(g/L)		CRP
	Median (Range)	p-Value	Median(Range)	p-Value
Gender
Male	1.10(0.15–1.80)	0.236	3.685(0.16–251.70)	0.083
Female	1.09(0.56–1.72)		2.60(0.10–92.96)
Age (years)
< 53	1.095(0.23–1.80)	0.539	4.08(0.16–210.65)	0.064
≥ 53	1.10(0.15–1.72)		2.89(0.10–251.70)
TNM stage
I-II	1.13(0.15–1.80)	< 0.001	2.255(0.10–241.15)	< 0.001
III-IV	1.03(0.16–1.64)		9.61(0.24–251.70)
Tumor size(cm)
< 5	1.13(0.15–1.80)	< 0.001	2.35(0.10–241.25)	< 0.001
≥ 5	1.03(0.16–1.64)		9.66(0.24–251.70)
Tumor number
Single	1.10(0.15–1.80)	0.544	2.73(0.10–251.70)	0.001
Multiple	1.10(0.41–1.64)		5.60(0.24–132.49)
Node stage
N0	1.10(0.15–1.80)	0.059	3.425(0.10–251.70)	0.005
N1–2	1.01(0.35–1.48)		8.03(0.57–194.10)
Distant metastases
No	1.10(0.15–1.80)	0.169	3.49(0.10–251.70)	0.008
Yes	1.04(0.16–1.56)		9.66(0.60–92.96)
BMI (kg/m2)
≥ 24.0	1.085(0.30–1.72)	0.756	2.89(0.16–241.25)	0.264
18.5–23.9	1.11(0.15–1.80)		4.03(0.10–251.70)
< 18.5	1.08(0.41–1.77)		4.75(0.25–146.40)
Alcohol behavior
Never	1.10(0.15–1.80)	0.802	3.59(0.10–194.10)	0.409
Previous/Current	1.08(0.16–1.65)		3.56(0.16–251.70)
Family history of cancer
No	1.10(0.15–1.80)	0.772	3.56(0.10–251.70)	0.403
Yes	1.10(0.16–1.77)		3.765(0.30–126.24)
HBs Ag
Negative	1.10(0.15–1.80)	0.664	3.28(0.23–251.70)	0.780
Positive	1.10(0.15–1.80)		3.56(0.10–210.65)
HBe Ag
Negative	1.07(0.15–1.80)	0.492	3.71(0.16–251.70)	0.754
Positive	1.12(0.16–1.52)		3.79(0.25–130.04)
HCV Ab
Negative	1.10(0.15–1.80)	0.197	3.64(0.10–251.70)	0.075
Positive	1.02(0.26–1.64)		1.88(0.23–194.10)
AFP (ng/mL)
< 400	1.11(0.16–1.80)	0.020	3.10(0.10–251.70)	< 0.001
≥ 400	1.04(0.15–1.58)		8.20(0.30–241.25)